Cystic Fibrosis Flashcards
Describe the nature of CF
GENETIC CONDITION
LIFE-LIMITING
Relate the CFTR channel to CF
MUTATION of ΔF 5O8 gene encoding for CFTR channel (Cl- movement) > faulty channel > reduced Cl- absorption > reduced Na+ & water absorption DEHYDRATION
Aims of treatment/management
Prevent long term complications
DIABETES
CHRONIC INFECTION
Maintain BMI, support growth & development
Clinical features of CF
THICK, STICKY MUCUS in lungs & pancreas Salty skin (high [Cl-] in sweat)
Outcomes:
PANCREATIC INSUFFICIENCY
Reduced lung function (FEV1)
COMPLICATIONS
Explain how CF causes pancreatic insufficiency
Pancreatic duct blocked by thick mucus
Cannot release digestive enzymes into SI
Reduced food digestion
Therapeutic treatment for babies with CF
Nutritional therapy (high cal drinks)
Multivits (fat soluble)
Pancreatic enzyme supplements (Creon)
Antibiotics
Monitoring in babies includes:
Head circumference, height, weight Pulmonary status Oropharyngeal cultures (bacteria) Glucose tolerance tests Bone density
Creon capsules:
Used for pancreatic insufficiency
PANCREATIC ENZYMES
DORNASE ALFA:
- Effects
- Mechanism
- Administration
- reduces mucus viscosity, expectoration, improves FEV1 (lung function)
- deoxyribonuclease I breaks down DNA fragments from neutrophil degradation
- INHALATION - jet nebuliser
CF babies: G+ bacteria eradication
SPECIFICALLY:
S. aureus
CF patients (older): G- bacteria eradication SPECIFICALLY:
P .aeruginosa
AZITHROMYCIN
- Dose
- Actions
500mg 3x weekly
Treat INFLAMMATION due to CHRONIC infection
improve FEV1
OGTT
- abnormal levels
- indication
- abbreviation
> 11mmol/L
DIABETES
Oral Glucose Tolerance Test
HbA1c
- abnormal levels
- sign of:
- pharmacological indication
> 6.5%
DIABETES
Glycosylated Hb due to XS sugar